Inactive Instrument

Other languages Biostage Inc Nasdaq

Equities

US41690A1060

End-of-day quote Nasdaq Other stock markets
- ^USD	-

04-15	Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding	CI
03-28	Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Biostage, Inc. Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	18/07/23
Biostage, Inc. Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31/05/23
Biostage Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31/05/23
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Biostage, Inc. Appoints Ron Packard to Board of Directors	10/04/23
Biostage, Inc. Auditor Raises 'Going Concern' Doubt	29/03/23
Biostage, Inc Announces Board Changes	02/03/23
Biostage, Inc Announces Executive Changes	02/03/23
Biostage, Inc. Amends CEO Employment Agreement	12/01/23
Biostage, Inc. Announces New Publication Demonstrates Rapid Esophageal Regeneration Using the Biostage Esophageal Implant	23/12/22
Insider Sell: Biostage	09/12/22
Biostage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Biostage, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/08/22
Biostage, Inc. Announces Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Journal of Biomechanics	15/06/22
Insider Buy: Biostage	23/05/22
Insider Buy: Biostage	23/05/22
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biostage Inc Nasdaq

Equities

US41690A1060

Other languages

Filters